The degradation of corticotropin-releasing factor by enzymes of the rat brain studied by liquid chromatography-mass spectrometry

Peptides

Volumn 19, Issue 4, 1998, Pages 649-658

  Kertscher, U ^a   Beyermann, M ^a   Krause, E ^a   Furkert, J ^a   Berger, H ^a   Bienert, M ^a   Mehlis, B ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

CRF; Enzymatic cleavage; HPLC; Inhibitors; Mass spectrometry

Indexed keywords

1,10 PHENANTHROLINE; CORTICOTROPIN RELEASING FACTOR; EDETIC ACID; ENZYME; METALLOPROTEINASE;

ANIMAL TISSUE; ARTICLE; BRAIN; ENZYME ACTIVITY; ENZYME DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROMETER;

ANIMALIA;

EID: 0032051881     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00013-8     Document Type: Article

References (47)

1. Apffel A., Fischer S., Goldberg G., Goodley P. C., Kuhlmann F. E. Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. J. Chromatogr. A. 712:1995;177-190.
2. Barrett, A. J.; Kembhavi, A. A.; Hanada, K. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases. Acta biol. Med. Germ. 40:1531-1517; 1981.
3. Bauer K. Purification and characterization of the thyrotropin-releasing-hormone-degrading ectoenzyme. Eur. J. Biochem. 224:1994;387-396.
4. Behan D. B., De Souza E. B., Lowry P. J., Potter E., Sawchenko P., Vale W. W. Corticotropin releasing factor (CRF) binding protein a novel regulator of CRF and related peptides . Frontiers Neuroendocinol. 16:1995;362-382.
5. Behan D. P., Heinrichs S. C., Troncoso J. C., Liu X.-J., Kawas C. H., Ling N., De Souza E. B. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature (London). 378:1995;284-287.
6. Behan D. P., Grigoriadis D. E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C., De Souza E. B. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein implications for the treatment of CNS disorders . Mol. Psychiat. 1:1996;265-277.
7. Beyermann M., Fechner K., Furkert J., Krause E., Bienert M. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. J. Med. Chem. 39:1996;3324-3330.
8. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
9. Brudel M., Kertscher U., Berger H., Mehlis B. Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of gonadotropin-releasing hormone. J. Chromatogr. A. 661:1994;55-60.
10. Brudel M., Kertscher U., Schröder D., Melzig M. F., Mehlis B. Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of -endorphin by endothelial cells. J. Chromatogr. A. 712:1995;169-175.
11. Burlingame A. L., Boyd R. K., Gaskell S. J. Mass spectrometry. Anal. Chem. 66:1994;634R-683R.
12. Candas B., Lalonde J., Normand M. Distribution and metabolism of corticotropin-releasing factor in the rat. Can. J. Physiol. Pharmacol. 64:1985;683-688.
13. Dathe M., Fabian H., Gast K., Zirwer D., Winter R., Beyermann M., Schümann M., Bienert M. Conformational differences of ovine and human corticotropin releasing hormone. Int. J. Pept. Protein Res. 47:1996;383-393.
14. Dauch P., Vincent J.-P., Checler F. Specific inhibition of endopeptidase 24.16 by dipeptides. Eur. J. Biochem. 202:1991;269-276.
15. Diamant M., de Wied D. Structure-related effects of CRF and CRF-derived peptides dissociation of behavioural, endocrine and autonomic activity . Neuroendocrinology. 57:1993;1071-1081.
16. t)-containing peptides. J. Chem. Soc., Chem. Commun. 1994:1994;853-854.
17. Feistner G. J., Faull K. F., Barofsky D. F., Roepstorff P. Mass spectrometric peptide and protein charting. J. Mass Spectrom. 30:1995;519-530.
18. Jones D. H., Matus A. I. Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta. 356:1974;276-287.
19. Kertscher U., Brudel M., Mehlis B., Sandow J., Berger H. Pathways of degradation of buserelin by rat kidney membrane. J. Pharmacol. Exp. Ther. 273:1995;709-715.
20. Konkoy C. S., Davis T. P. Ectoenzymes as sites of peptide regulation. Trends Pharmacol. Sci. 17:1997;288-294.
21. Krause E., Beyermann M., Dathe M., Rothmund S., Bienert M. Location of an amphipathic helix in peptides using reversed-phase HPLC retention behavior of D-amino acid analogs. Anal. Chem. 34:1995;252-258.
22. Lebouille J. L. M., Hendriks R. W., Soeter N. M., Burbach J. P. H. Properties of a Leu-Phe-cleaving endopeptidase activity putatively involved in -endorphin metabolism in rat brain. J. Neurochem. 52:1989;1714-1721.
23. Lew R. A., Hey N. J., Tetaz T. J., Glucksman M. J., Roberts J. L., Smith I. A. Substrate specificity differences between recombinant rat testes endopeptidase EC 3.4.24.15 and the native brain enzyme. Biochem. Biophys. Res. Commun. 209:1995;788-795.
24. Linton E. A., McLean C., Nieuwenhuyzen Kruseman A. C., Tilders F. J., Van der Veen E. A., Lowry P. J. Direct measurement of human plasma corticotropin-releasing hormone by "two-site" immunoradiometric assay. J. Clin. Endocrinol. Metabol. 64:1987;1047-1053.
25. Mehlis B., Kertscher U. Liquid chromatography/mass spectrometry of peptides in biological samples. Anal. Chim. Acta. 352:1997;71-83.
26. O'Cuinn G., O'Connor B., Gilmartin L., Smyth M. Neuropeptide inactivation by peptidases. O'Cuinn G. Metabolism of Brain Peptides. 1995;99-157 CRC Press, Boca Raton, FL.
27. Orlowski M., Michaud C., Chu T. G. A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural substrates. Eur. J. Biochem. 135:1983;81-88.
28. Papayannopoulos I. A. The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spectrom. Rev. 14:1995;49-73.
29. Petrusz P., Merchenthaler I. The corticotropin-releasing factor system. Nemeroff X. Neuroendocrinology. 1992;129-183 CRC Press, Boca Raton, FL.
30. Potter E., Behan D. P., Fischer W. H., Linton E. A., Lowry P. J., Vale W. W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature (London). 349:1991;423-426.
31. Rivier J., Spiess J., Vale W. Characterization of rat hypothalamic corticotropin-releasing factor. Proc. Natl. Acad. Sci. USA. 80:1983;4851-4855.
32. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin-releasing factor effect on ACTH secretion in the rat . Science (Washington DC). 224:1984;889-891.
33. Rivier J., Rivier C., Galyean R., Miranda A., Miller C., Craig A. G., Yamamoto G., Brown M., Vale W. Single point D-substituted corticotropin-releasing factor analogues effects on potency and physicochemical characteristics . J. Med. Chem. 36:1993;2851-2859.
34. Roques B. P., Noble F., Dauge V., Fournie-Zaluski M.-C., Beaumont A. Neutral endopeptidase 24.11 structure, inhibition, and experimental and clinical pharmacology . Pharmacol. Rev. 45:1993;87-145.
35. Rückert Y., Rohde W., Furkert W. Radioimmunoassay of corticotropin-releasing hormone. Exp. Clin. Endocrinol. 96:1990;129-137.
36. Saphier P. W., Faria M., Grossman A., Coy D. H., Besser G. M., Hodson B., Parkes M., Linton E. A., Lowry P. J. A comparison of the clearance of ovine and human corticotropin-releasing hormone (CRH) in man and sheep a possible role for CRH-binding protein . J. Endocrinol. 133:1992;487-495.
37. Schauder B., Schomburg L., Köhrle J., Bauer K. Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc. Natl. Acad. Sci. USA. 91:1994;9534-9538.
38. Schürmeyer T. H., Schulte H. M., Avgerinos P. C., Topai T. P., Loriaux D. L., Gold P. W., Chrousos G. P. Pharmacology of ovine and human CRH. Horm Meta Res Suppl. 16:1987;24-30.
39. Shibahara S., Morimoto Y., Furutani Y., Notaka H., Takahashi H., Shimizu S., Horikawa S., Numa S. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J. 2:1983;775-779.
40. Smith A. I., Engler D., Fullerton M. J., Pham T., Wallace C., Morgan F. J., Clarke I. J., Funder J. W. Posttranslational processing of corticotropin-releasing factor in the ovine tuberoinfundibular system and pituitary. Ann. N. Y. Acad. Sci. 512:1987;24-47.
41. Spiess J., Rivier J., Rivier C., Vale W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl. Acad. Sci. USA. 78:1981;6517-6521.
42. Turner A. J., Murphy L. J. Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51:1996;91-102.
43. Ulisse S., Fabbri A., Dudau M. L. Corticotropin-releasing factor receptors and action in rat Leydig cells. J. Biol. Chem. 264:1989;2156-2163.
44. Vale V., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and endorphin. Science (Washington DC). 213:1981;1394-1397.
45. Vale W., Rivier C., Brown M. R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Progr. Hormone Res. 39:1983;245-269.
46. Vaughan J., Donaldson C., Bittencourt J., Perrin M. H., Lewis K., Sutton S., Chan R., Turnbull A. V., Lovejoy D., Rivier C., Sawchenko P. E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (London). 378:1995;287-292.
47. Yates J. R. III, McCormack A. L., Link A. J., Schieltz D., Eng J., Hays L. Future prospects for the analysis of complex biological systems using liquid chromatography-electrospray tandem mass spectrometry. Analyst. 121:1996;65R-76R.